ZEO Scientifix Inc. has announced a partnership with Cytora Therapeutics and Made Scientific to manufacture and commercialize Cytora’s allogeneic oral mucosal stem cell therapy in the United States. Under the collaboration, Cytora will provide manufacturing rights and continue clinical and regulatory development, Made Scientific will serve as the exclusive U.S. manufacturing partner with GMP-compliant facilities in Princeton, New Jersey, and ZEO Scientifix will act as the exclusive U.S. commercial partner, managing market access, distribution, and clinical site operations. The partnership aims to expand patient access to innovative stem cell therapies for non-healing diabetic foot ulcers and other indications, leveraging recent legislative developments in Florida and other states.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY57861) on January 07, 2026, and is solely responsible for the information contained therein.